Cutaneous injection of RANTES causes eosinophil recruitment: comparison of nonallergic and allergic human subjects.

RANTES, a member of the C-C chemokine family, is a potent chemoattractant for T lymphocytes and eosinophils, but not neutrophils. To determine the effect of RANTES on cell recruitment in vivo, we injected up to 4 microg of RANTES intradermally into both allergic and nonallergic subjects and obtained biopsies 30 min, 6 h, and 24 h later. A dose- and time-dependent recruitment of eosinophils, CD45RO+ cells, and CD3+ cells was observed, with no effect seen on polymononuclear, cutaneous lymphocyte Ag+, CD68+, or tryptase+ cells. Eosinophil recruitment occurred more rapidly in allergic subjects than in nonallergic subjects. No eosinophil infiltrate was observed in nonallergic biopsies at 30 min and 6 h, whereas significant eosinophil recruitment was observed in allergic subjects by 30 min, reaching near-maximum levels by 6 h. The peak responses at 24 h were similar in both groups (nonallergic, 110 +/- 24 eosinophils/mm2; allergic, 113 +/- 38 eosinophils/mm2). The two groups had comparable numbers of circulating eosinophils. Major basic protein staining demonstrated eosinophil degranulation in both allergic and nonallergic groups. RANTES injection resulted in activation of endothelial E-selectin expression at 24 h. Incubation of cultured HUVECs with RANTES had no effect on adhesion molecule expression, suggesting that the in vivo effect may have been indirect. Our studies demonstrate that RANTES is a potent chemoattractant for eosinophils, CD3+ cells, and CD45RO+ cells in human skin. The accelerated eosinophil recruitment in allergic subjects provides support for the hypothesis that eosinophils from these subjects are primed in vivo.

• Publication year

  1997

• Venue

  Journal of Immunology

• Publication date

  1997-09-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.4049/jimmunol.159.6.2962PMID 9300720
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines.

  1997cited by this paper
• Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.

  1996cited by this paper
• Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung.

  1996cited by this paper
• Detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps.

  1996cited by this paper
• Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways.

  1996cited by this paper
• Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia

  1996cited by this paper
• Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients.

  1996cited by this paper
• Expression of granulocyte/macrophage-colony-stimulating factor, interleukin-8 and RANTES in the bronchial epithelium of mild asthmatics is down-regulated by inhaled beclomethasone dipropionate.

  1995cited by this paper
• Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids.

  1995cited by this paper
• Activation of dual T cell signaling pathways by the chemokine RANTES.

  1995cited by this paper
• Glucocorticoid inhibition of RANTES expression in human lung epithelial cells.

  1995cited by this paper
• The integrin VLA-4 supports tethering and rolling in flow on VCAM-1

  1995cited by this paper
• Bone marrow-derived murine mast cells migrate, but do not degranulate, in response to chemokines.

  1995cited by this paper
• CC chemokines in allergic inflammation.

  1994cited by this paper
• IL-4 induces chemotaxis of blood eosinophils from atopic dermatitis patients, but not from normal individuals.

  1994cited by this paper
• Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine

  1994cited by this paper
• Human RANTES induces the migration of human T lymphocytes into the peripheral tissues of mice with severe combined immune deficiency

  1994cited by this paper
• Pulmonary function, activated T cells, peripheral blood eosinophilia, and serum activity for eosinophil survival in vitro: a longitudinal study in bronchial asthma.

  1994cited by this paper
• Eosinophil transendothelial migration induced by cytokines. II. Potentiation of eosinophil transendothelial migration by eosinophil-active cytokines.

  1994cited by this paper
• Induction of low density and up-regulation of CD11b expression of neutrophils and eosinophils by dextran sedimentation and centrifugation.

  1994cited by this paper
• Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES.

  1994cited by this paper
• L-selectin and very late antigen-4 integrin promote eosinophil rolling at physiological shear rates in vivo.

  1994cited by this paper
• The role of adhesion molecules in human eosinophil and basophil recruitment.

  1994cited by this paper
• Eosinophil migration in atopic dermatitis. I: Increased migratory responses to N-formyl-methionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet-activating factor, and platelet factor 4.

  1993cited by this paper
• RANTES is a chemotactic and activating factor for human eosinophils.

  1993cited by this paper
• RANTES and related chemokines activate human basophil granulocytes through different G protein‐coupled receptors

  1993cited by this paper
• The effects of the potent glucocorticoid budesonide on adhesion of eosinophils to human vascular endothelial cells and on endothelial expression of adhesion molecules.

  1993cited by this paper
• Mast cells, neutrophils, and eosinophils in prurigo nodularis.

  1993cited by this paper
• P-selectin mediates spontaneous leukocyte rolling in vivo.

  1993cited by this paper
• Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8

  1993cited by this paper
• Appearance of granulocyte-macrophage colony-stimulating factor activity at allergen-challenged cutaneous late-phase reaction sites.

  1993cited by this paper
• IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction.

  1993cited by this paper
• Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1 beta-induced transendothelial migration.

  1992cited by this paper
• RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes

  1992cited by this paper
• Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia.

  1992cited by this paper
• Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils

  1992cited by this paper
• Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule 1.

  1991cited by this paper
• Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity.

  1991cited by this paper
• Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes.

  1991cited by this paper
• Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects

  1991cited by this paper
• ELAM-1 is an adhesion molecule for skin-homing T cells

  1991cited by this paper
• Mechanisms of eosinophil adherence to cultured vascular endothelial cells. Eosinophils bind to the cytokine-induced ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor.

  1991cited by this paper
• The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1

  1991cited by this paper
• Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES

  1990cited by this paper
• A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites.

  1990cited by this paper
• Superoxide generation by hypodense eosinophils from patients with asthma.

  1990cited by this paper
• Human endothelial cells prolong eosinophil survival. Regulation by cytokines and glucocorticoids.

  1989cited by this paper
• The appearance of hypodense eosinophils in antigen-dependent late phase asthma.

  1989cited by this paper
• Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Role of the epithelium.

  1988cited by this paper
• Hypodense eosinophils in allergic rhinitis.

  1988cited by this paper
• The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity.

  1988cited by this paper
• Skin eosinophilia in atopic patients.

  1988cited by this paper
• Eosinophils cocultured with endothelial cells have increased survival and functional properties.

  1987cited by this paper
• The eosinophilic leukocyte and the pathology of fatal bronchial asthma: evidence for pathologic heterogeneity.

  1987cited by this paper
• Accumulation of eosinophils in response to intracutaneous PAF-acether and allergens in man.

  1986cited by this paper
• Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters.

  1986cited by this paper
• Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis.

  1985cited by this paper
• Episodic angioedema associated with eosinophilia.

  1984cited by this paper
• Activation of basophil and mast cell histamine release by eosinophil granule major basic protein

  1983cited by this paper
• Localization of eosinophil granule major basic protein in chronic urticaria.

  1983cited by this paper
• Altered density, metabolism and surface receptors of eosinophils in eosinophilia.

  1982cited by this paper

• Anti-inflammatory, ulcerogenic and platelet activation evaluation of novel 1,4-diaryl-1,2,3-triazole neolignan-celecoxib hybrids.

  2021cites this paper
• Legends of allergy and immunology: Robert P. Schleimer

  2021cites this paper
• NLRX1 is a key regulator of immune signaling during invasive pulmonary aspergillosis

  2020cites this paper
• Aronia melanocarpa Fruit Bioactive Fraction Attenuates LPS-Induced Inflammatory Response in Human Bronchial Epithelial Cells

  2020cites this paper
• Description of the Follicular Fluid Cytokine and Hormone Profiles in Human Physiological Natural Cycles

  2020cites this paper
• Immunological Perspectives: Th2 Cells/Mast Cells/Basophils/Eosinophils

  2018cites this paper
• Vitamin D decreases the secretion of eotaxin and RANTES in nasal polyp fibroblasts derived from Taiwanese patients with chronic rhinosinusitis with nasal polyps

  2015cites this paper
• the multistep paradigm chemokines in T-cell transmigration: implications for locomotion and dependent integration of apical and subendothelial - Shear flow

  2013cites this paper
• Glucocorticoid Budesonide C-C Chemokine Expression by IL-4 and the Differential Regulation of Epithelial-Derived

  2013cites this paper
• Chemokines and chemokine receptors blockers as new drugs for the treatment of chronic obstructive pulmonary disease.

  2013cites this paper
• Quantifying monocyte infiltration in response to intradermal tetanus toxoid injection.

  2012cites this paper
• Comparison of Timothy grass pollen extract‐ and single major allergen‐induced gene expression and mediator release in airway epithelial cells: a meta‐analysis

  2012cites this paper
• Urban particulate matter in Beijing, China, enhances allergen-induced murine lung eosinophilia

  2010influential citation
• IL-6, VEGF, KC and RANTES are a major cause of a high irritant dermatitis to phthalic anhydride in C57BL/6 inbred mice.

  2010cites this paper
• Lysophosphatidic Acid Inhibits CC Chemokine Ligand 5/RANTES Production by Blocking IRF-1–Mediated Gene Transcription in Human Bronchial Epithelial Cells

  2010cites this paper
• Epithelial Transcription in Human Bronchial Mediated Gene - by Blocking IRF-1 Chemokine Ligand 5/RANTES Production Lysophosphatidic Acid Inhibits CC

  2010cites this paper
• The Relative Activity of “Function Sparing” HIV-1 Entry Inhibitors on Viral Entry and CCR5 Internalization: Is Allosteric Functional Selectivity a Valuable Therapeutic Property?

  2009cites this paper
• Distribution of eosinophil granulocytes and mast cells in the reproductive tract of female goats in the preimplantation phase

  2009cites this paper
• Skin reactivity and local cell recruitment in human atopic and nonatopic subjects by CCL2/MCP‐1 and CCL3/MIP‐1α

  2008cites this paper
• A follow‐up study of immunotherapy‐treated birch‐allergic patients: effect on the expression of chemokines in the nasal mucosa

  2008cites this paper
• Neuropeptides activate human mast cell degranulation and chemokine production

  2008cites this paper
• Shear flow-dependent integration of apical and subendothelial chemokines in T-cell transmigration: implications for locomotion and the multistep paradigm.

  2007cites this paper
• Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders.

  2007cites this paper
• Phase I Evaluation of the Safety, Pharmacokinetics and Pharmacodynamics of CP-481,715

  2007cites this paper
• Current status of CCR1 antagonists in clinical trials

  2007cites this paper
• Structural Basis for the Interaction of CCR5 with a Small Molecule, Functionally Selective CCR5 Agonist

  2006cites this paper
• CCR5 usage by CCL5 induces a selective leukocyte recruitment in human skin xenografts in vivo.

  2006cites this paper
• The effect of etanercept on the human cutaneous allergic response.

  2006cites this paper
• Neuropeptides activate human mast cell degranulation and chemokine production.

  2006cites this paper
• The Human Specific CCR1 Antagonist CP-481,715 Inhibits Cell Infiltration and Inflammatory Responses in Human CCR1 Transgenic Mice

  2006cites this paper
• Increased Expression of RANTES, CCR3 and CCR5 in the Lesional Skin of Patients with Atopic Eczema

  2006cites this paper
• In vivo evaluation of therapeutic options in atopic dermatitis

  2006cites this paper
• Transgenic Mice Inflammatory Responses in Human CCR 1 CP-481 , 715 Inhibits Cell Infiltration and The Human Specific CCR 1 Antagonist

  2006cites this paper
• The therapeutic potential in targeting CCR5 and CXCR4 receptors in infectious and allergic pulmonary disease.

  2005cites this paper
• Anti‐IL‐5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis

  2005cites this paper
• Chemokines and Chemokine Receptors in Pulmonary Disease

  2005cites this paper
• Chemokine receptor expression by mast cells.

  2005cites this paper
• Double-stranded RNA activates RANTES gene transcription through co-operation of nuclear factor-kappaB and interferon regulatory factors in human airway epithelial cells.

  2004cites this paper
• Chemokine receptor antagonists: a novel therapeutic approach

  2004cites this paper
• Omalizumab-induced reductions in mast cell FcεRI expression and function

  2004cites this paper
• The Role of RANTES in a Murine Model of Food Allergy

  2004influential citation
• Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases

  2004influential citation
• Omalizumab-induced reductions in mast cell Fce psilon RI expression and function.

  2004cites this paper
• What is Urticaria? Anatomical, Physiological and Histological Considerations and Classification

  2004cites this paper
• Double‐stranded RNA activates RANTES gene transcription through co‐operation of nuclear factor‐κB and interferon regulatory factors in human airway epithelial cells

  2004cites this paper
• Role of Chemokines in Vernal Keratoconjunctivitis

  2003cites this paper
• Targeting the Chemokine System

  2003cites this paper
• CP-481,715, a Potent and Selective CCR1 Antagonist with Potential Therapeutic Implications for Inflammatory Diseases*

  2003cites this paper
• Enhanced mucosal and systemic immune responses to a vaginal vaccine coadministered with RANTES-expressing plasmid DNA using in situ-gelling mucoadhesive delivery system.

  2003cites this paper
• 5-oxo-6,8,11,14-eicosatetraenoic acid induces the infiltration of granulocytes into human skin.

  2003cites this paper
• Human Atopic and Nonatopic Volunteers Reactions Following Cutaneous Injection in Features of Early-and Late-Phase Allergic Neutrophils , and Macrophages As Well As Basophils , Induce Recruitment of Eosinophils , Eotaxin ( CCL 11 ) and Eotaxin-2 ( CCL 24 )

  2002cites this paper
• Regulation of RANTES promoter activation in alveolar epithelial cells after cytokine stimulation.

  2002cites this paper
• Expression of a chemokine by ciliary body epithelium in horses with naturally occurring recurrent uveitis and in cultured ciliary body epithelial cells.

  2002cites this paper
• Lack of association between atopic eczema/dermatitis syndrome and polymorphisms in the promoter region of RANTES and regulatory region of MCP‐1

  2002cites this paper
• Hepatitis C: Magnitude of the problem

  2002cites this paper
• What is eotaxin doing in the pleura? Insights into innate immunity from pleural mesothelial cells.

  2002cites this paper
• Increased responsiveness of murine eosinophils to MIP‐1β (CCL4) and TCA‐3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8

  2002cites this paper
• Eosinophils and Atopic Dermatitis

  2002cites this paper
• Eotaxin (CCL11) and Eotaxin-2 (CCL24) Induce Recruitment of Eosinophils, Basophils, Neutrophils, and Macrophages As Well As Features of Early- and Late-Phase Allergic Reactions Following Cutaneous Injection in Human Atopic and Nonatopic Volunteers1

  2002cites this paper
• Functional Expression and Characterization of Macaque C-C Chemokine Receptor 3 (CCR3) and Generation of Potent Antagonistic Anti-macaque CCR3 Monoclonal Antibodies*

  2002cites this paper
• Mast cells, basophils, and eosinophils: distinct but overlapping pathways for recruitment

  2001cites this paper
• Differential expression of RANTES chemokine, TGF-beta, and leukocyte phenotype in acute cellular rejection and quilty B lesions.

  2001cites this paper
• RANTES Potentiates Antigen-Specific Mucosal Immune Responses1

  2001cites this paper
• Chemokine-induced cutaneous inflammatory cell infiltration in a model of Hu-PBMC-SCID mice grafted with human skin.

  2001cites this paper
• Differential expression and secretion of RANTES and MCP-1 in activated peripheral blood mononuclear cell cultures of atopic subjects.

  2001cites this paper
• Selective recruitment of Th2‐type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein‐II

  2001cites this paper
• Systemic activation of basophils and eosinophils: markers and consequences.

  2000cites this paper
• Allergen sensitization through the skin induces systemic allergic responses.

  2000cites this paper
• Inflammatory Processes:

  2000cites this paper
• Pathogenic roles of eosinophils in guinea‐pig contact sensitivity: regulation of dermal eosinophilia with remotely administered IL‐5

  2000cites this paper
• Eosinophils in the human corpus luteum: the role of RANTES and eotaxin in eosinophil attraction into periovulatory structures.

  2000cites this paper
• Expression of RANTES by IL-1 beta and TNF-alpha stimulated nasal polyp fibroblasts.

  2000cites this paper
• Cutaneous Injection of Human Subjects with Macrophage Inflammatory Protein-1α Induces Significant Recruitment of Neutrophils and Monocytes1

  2000cites this paper
• Microvascular Endothelial Cells Differ in Their Basal and Tumour Necrosis Factor-α-Regulated Expression of Adhesion Molecules and Cytokines

  2000cites this paper
• Chemokines in the limbal form of vernal keratoconjunctivitis

  2000cites this paper
• Expression of eosinophil-specific chemokines by human epithelial cells.

  2000cites this paper
• Role of chemokines in asthmatic airway inflammation

  2000cites this paper
• Are chemokines essential or secondary participants in allergic responses?

  2000cites this paper
• Activation of human eosinophils by chemokines.

  2000cites this paper
• Road signs guiding leukocytes along the inflammation superhighway.

  2000cites this paper
• Expression of RANTES by IL-1 β and TNF-α stimulated nasal polyp fibroblasts

  2000cites this paper
• The role of chemokines in allergic diseases of the airways

  2000cites this paper
• Immunological aspects of allergic inflammation: eosinophils

  2000cites this paper
• The role of T cells in the pathogenesis of atopic dermatitis

  2000cites this paper
• Chemokine Receptors: Therapeutic Targets For Human Immunodeficiency Virus Infectivity

  2000cites this paper
• Cell-to-cell interactions

  2000cites this paper
• Mucosal Immune Responses RANTES Potentiates Antigen-Specific

  2000cites this paper
• Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation.

  1999cites this paper
• Biochemical and immunologic mechanisms in atopic dermatitis: new targets for emerging therapies.

  1999cites this paper
• Chemokines: signal lamps for trafficking of T and B cells for development and effector function

  1999cites this paper
• Strategies to interfere with the chemokine network in disease.

  1999cites this paper
• Contrasting roles for RANTES and macrophage inflammatory protein‐1α (MIP‐1α) in a murine model of allergic peritonitis

  1999cites this paper
• The CC Chemokine MIP-1α Induces a Selective Monocyte Infiltration Following Intradermal Injection into Nonhuman Primates

  1999cites this paper
• RANTES Production by Cultured Primate Endometrial Epithelial Cells

  1999cites this paper
• LES CHÉMOKINES : des cibles thérapeutiques potentielles de l'asthme au VIH

  1999cites this paper
• HETEROGENOUS RANTES EXPRESSION OF HUMAN AIRWAY FIBROBLASTS BY LPS FROM NOSE AND OTHER THE AIRWAYS

  1999cites this paper
• Contrasting roles for RANTES and macrophage inflammatory protein-1 alpha (MIP-1 alpha) in a murine model of allergic peritonitis.

  1999cites this paper
• Potential Roles for Chemokines in Transplant Rejection

  1999cites this paper
• Regulation and modulation of eosinophil effector functions

  1999cites this paper
• Cloning of bovine RANTES mRNA and its expression and regulation in ovaries in the periovulatory period

  1999cites this paper